Coloplast A/S (CLPBF)
PNK: CLPBF
· Real-Time Price · USD
98.09
-8.16 (-7.68%)
At close: May 07, 2025, 10:10 AM
Coloplast A/S Cash Flow Statement
Financials in DKK. Fiscal
year is
October - September.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | 6.27B | 6.24B | 5.98B | 6.42B | 6.82B | 6.77B | 6.9B | 6.93B | 6.58B | 6.44B | 6.31B | 6.16B | 6.23B | 6.16B | 5.98B | 5.75B | 5.92B |
Depreciation & Amortization | 1.31B | 1.29B | 1.23B | 1.17B | 1.12B | 1.07B | 1.05B | 1.05B | 1.02B | 930M | 862M | 811M | 765M | 792M | 816M | 821M | 845M |
Stock-Based Compensation | 3M | 2M | 58M | 57M | 54M | 55M | 33M | 47M | 46M | 49M | 66M | 56M | 58M | 53M | 42M | 41M | 40M |
Other Working Capital | 411M | 338M | 27M | 13M | -39M | 11M | 225M | 82M | -801M | -668M | -516M | -331M | -59M | 86M | -13M | 93M | 1M |
Other Non-Cash Items | -2.38B | -2.27B | -2.31B | -3.29B | -1.9B | -2.72B | -2.47B | -2.03B | -1.73B | -1.42B | -1.45B | -1.56B | -1.53B | -1.58B | -1.49B | -1.18B | -1.4B |
Deferred Income Tax | n/a | 1M | -55M | -54M | -54M | -55M | -33M | -47M | -47M | -47M | -13M | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -748M | -1.03B | -835M | -557M | -504M | -893M | -1B | -1.05B | -1.41B | -849M | -815M | -696M | -258M | -75M | -276M | -318M | -427M |
Operating Cash Flow | 2.98B | 2.77B | 2.6B | 2.28B | 5.53B | 4.23B | 4.49B | 4.89B | 4.46B | 5.1B | 4.91B | 4.71B | 5.21B | 5.29B | 5.02B | 5.08B | 4.94B |
Capital Expenditures | -1.38B | -1.35B | -1.29B | -1.23B | -1.24B | -1.24B | -1.26B | -1.23B | -1.21B | -1.14B | -1.02B | -977M | -937M | -1.97B | -1.92B | -1.92B | -1.94B |
Cash Acquisitions | 200M | 16M | -7.91B | -7.91B | -7.91B | -7.92B | 4M | 6M | 11M | 11M | 10M | -31M | -96M | -96M | -96M | -58M | n/a |
Purchase of Investments | -34M | -21M | -21M | -22M | -26M | -18M | -18M | -19M | -2M | -2M | -16M | 11M | 11M | 11M | 25M | n/a | n/a |
Sales Maturities Of Investments | -8M | n/a | n/a | 16M | 224M | 216M | 216M | 199M | -1M | -1M | -2M | 29M | 29M | 30M | 31M | 1M | 1M |
Other Investing Acitivies | -165M | -138M | -93M | -50M | 135M | 57M | -41M | -41M | -10.79B | -10.74B | -10.66B | -10.66B | -91M | -62M | -72M | -40M | 24M |
Investing Cash Flow | -1.2B | -1.34B | -9.21B | -9.13B | -8.95B | -8.96B | -1.06B | -1.04B | -11.83B | -11.76B | -11.66B | -11.59B | -986M | -2.01B | -1.98B | -1.95B | -1.91B |
Debt Repayment | 212M | -1.96B | -149M | -252M | -759M | -763M | -2.54B | -2.96B | -2.45B | -2.43B | -645M | 20M | 28M | 2.99B | 2.99B | 2.76B | 2.76B |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -48M | -184M | -619M | -619M | -729M | -874M | -500M | -500M | -386M | -384M | -500M |
Dividend Paid | -4.96B | -4.72B | -4.72B | -4.66B | -4.66B | -4.25B | -4.25B | -4.25B | -4.25B | -4.04B | -4.04B | -4.04B | -4.04B | -3.83B | -3.83B | -3.83B | -3.83B |
Other Financial Acitivies | 2.52B | 4.66B | 2.17B | 2.68B | -100M | 1.14B | 3.64B | 3.66B | 14.66B | 13.62B | 12.17B | 11.66B | 185M | -2.14B | -2.02B | -2.08B | -1.93B |
Financial Cash Flow | -1.8B | -1.52B | 6.65B | 7.14B | 3.71B | 5.26B | -3.16B | -3.73B | 7.41B | 6.59B | 6.89B | 6.96B | -4.05B | -3.18B | -3.02B | -3.21B | -3.07B |
Net Cash Flow | -10M | -123M | 32M | 261M | 245M | 497M | 221M | 111M | 29M | -34M | 187M | 99M | 207M | 125M | 36M | -80M | -81M |
Free Cash Flow | 1.61B | 1.42B | 1.31B | 1.05B | 4.29B | 2.98B | 3.23B | 3.66B | 3.25B | 3.96B | 3.89B | 3.73B | 4.27B | 3.32B | 3.1B | 3.16B | 3B |